Dr. Gary Karlin Urologist Lawrenceville NJ

Meet Gary S. Karlin, MD

Medical School

University of Health Sciences, The Chicago Medical School – North Chicago, IL

Internship & Residency

Long Island Jewish Medical Center – New Hyde Park, NY

Languages Spoken

English

Ages Served

18+

Dr. Gary Karlin graduated cum laude from Brandeis University in Waltham, MA, and earned his medical degree from the University of Health Sciences at The Chicago Medical School. He served his residency in surgery and urology at the department of general surgery at Long Island Jewish Medical Center in New Hyde Park, NY.

Dr. Karlin is certified by the American Board of Urology and is a Fellow of the American College of Surgeons. He is a member of various medical and professional societies including the American Medical Association and the American Urologic Association.

In addition to meeting the demands of a busy practice, Dr. Karlin has served on many executive committees and has authored presentations, journal articles, book chapters and participated in videos and clinical investigations. He is the founder of the Prostate Cancer Support Group and Impotency Anonymous at Capital Health System in Trenton, New Jersey.

Dr. Karlin is very active in clinical research, he has conducted trials since 1985 and served as the Principal Investigator for over 100 studies. He completed his clinical trial education through the Academy of Pharmaceutical Physicians and Investigators in 2006 for which he received his certification as a Physician Investigator (CPI).

SPECIALTIES

      LAWRENCEVILLE

      2 Princess Road, Suite J
      Lawrenceville, NJ 08648

      P: (609) 895-1991

      • Capital Health
      • Robert Wood Johnson University Hospital in Hamilton
      • Francis Medical Center
      • Capital Health Surgical Center
      • Fellow, American College of Surgery
      • American Medical Association
      • Mercer County Medical Society

      Publications:

      1. Munoz, E., Mallett, E., Karlin, G. and Moldwin, R.: Prospective Payment Systems (PPS), Diagnosis Related Groups (DRGS) and the Urologist. World Urology Update Series, 2(29), 1985
      2. Smith, A.D., Moldwin, R. and Karlin, G.: Percutaneous Ureterostomy. J. Urol., 138:286, 1987.
      3. Karlin, G., Rich, M., Lee, W. and Smith, A.D.: Endourological Management of Upper Tract Fungal Infection. Endourol. L (l): 49, 1987.
      4. Karlin, G., Smith, A. and Greenberg, I.: An Integrated Support System for Endourological Surgery. Endourol. 1(2):85, 1987.
      5. Smith, A.D., Moldwin, R. and Karlin, G.: Advanced Endourologic Techniques: Percutaneous Ureterostomy. J. Endourol. 2(3):13, 1987.
      6. Karlin, G., Smith, A.D., Lee, W. and Sutton, A.: Nondilated Obstructive Uropathy. Endourol. 2(l):35, 1988.
      7. Karlin, G., Badlani, G. and Smith, A.D.: Endopyelotomy versus Open Pyeloplasty: Comparison in 88 Patients.  J. Urol., 140(3): 476, 1988.
      1. Badlani, G., Karlin, G. and Smith, A.D.: Complications of endopyelotomy: Analysis in Series of 64 Patients. Urol., 140(3): 473, 1988.
      2. Lee, W., Badlani, G., Karlin, G. and Smith, A.D.: Treatment of Ureteropelvic Strictures with Percutaneous Pyelotomy: Experience in 62 Patients. Am. J. Roentgenol., 151:515, t988.
      3. Badlani, G., Karlin, G. and Smith, A.D.: Endopyelotomy. Comprehensive Therapy. (Accepted for Publication)
      4. Karlin, G., Brock, W., Rich, M and Pena, A.: Accessory Phallic Urethra and persistent Cloaca. Urol. 142:1056, 1989.
      5. Karlin, G. and Smith, A.D.: Percutaneous Access to the Superior Calyx: A New Technique. Urol. 142:774, 1989.
      6. G S Karlin, A D Smith: Greenberg surgical support system for the endourologist: Urol Clin North Am. (Vol. 17, Issue 1, Pages 107-9) Feb 1990.
      7. G S Karlin, G H Badlani: Endourologic management of lower urinary tract dysfunction: Clin Geriatr Med. (Vol. 6, Issue 1, Pages 109-13) Feb 1990.
      8. Karlin, G., Schulsinger, D., Urivetsky, M. and Smith, A.D.: Absence of Persisting Parenchymal Damage after Extracorporeal Shock Wave Lithotripsy as Judged by Excretion of renal Tubular Enzymes. Urol., 144(1) 13,1990.
      9. Karlin, G., Badlani, G. and Smith, A.D.: Endopyelotomy: Percutaneous Pyeloplasty for Congenital UPJ Obstruction. Urology,34(6): 533,1992
      10. Karlin, G.: Male Sexual Dysfunction. Mercer Medical Center Newsletter. 1993.
      11. Karlin, G.: Benign Prostatic Hyperplasia – Update. Mercer Medical Center Newsletter. 1994.
      12. Karlin, G.: Impotence – A Comprehensive Review. Journal of the Mercer County Medical Society. 1994.
      13. Karlin, G.: Evolving Treatment Options For BPH. Mercer Medical Center Medical Staff Newsletter, Winter 1997.
      14. Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, Padma-Nathan H.: Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl. ;23(6):763-71 Nov-Dec 2002.
      15. Brock, G., Lipshultz, L., Karlin, G.S., Gleave, M., Seger, M. Padma-Nathan, H.: Safety and Efficacy of Vardenafil for the Treatment of Men with Erectile Dysfunction Subsequent to Radical Retropubic Prostatectomy. J. Urol.;170:1278-1283, 2003.
      16. Hellstrom WJG, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, Padma-Nathan H: Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial. Urology: April 2003 (Vol. 61, Issue 4 (Supplement 1), Pages 8-14)
      17. Crawford, D.E., Sartor O., Chu, F., Perez, R., Karlin, G., Garrett, S.: A Twelve Month Clinical Study of LA-2585 45.0 MG:  A new 6 Month, Subcutaneous Delivery System for Leuprolide Acetate for the treatment of Prostate Cancer Journal of Urology, December 2004.
      18. Giuliano F, Donatucci C, Montorsi F, Auerbach S, Karlin G, Norenberg C, Homering M, Segerson T, Eardley I; Vardenafil Study Group: Vardenafil is effective and well-tolerated for treating erectile dysfunction in a broad population of men, irrespective of age BJU Int., January 2005.
      19. Fisher WA, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P, Goldstein I, Bangerter K, Bandel TJ, Derogatis LR, Sand M: Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil J Sex Med; (2(5):699-708) Sep 2005.
      20. Polascik TJ, Given RW, Metzger C, Julian SR, Vestal JC, Karlin GS, Barkley CS, Bilhartz DL, McWhorter LT, Lacerna LV: Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases Urology, (Vol. 66, Issue 5, Pages 1054-1059) November 2005.
      21. Goldstein I, Fisher WA, Sand M, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P, Bangerter K, Bandel TJ, Derogatis LR; Vardenafil Study Group: Women’s sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial J Sex Med, (2(6):819-32) Nov. 2005
      22. Goldstein I, Fisher WA, Sand M, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P, Bangerter K, Bandel TJ, Derogatis LR; Vardenafil Study Group. Women’s sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial J Sex Med. ;2(6):819-32 Nov. 2005.
      23. Crawford, D.E., Sartor O., Chu, F., Perez, R., Karlin, G., Garrett, S.: A Twelve Month Clinical Study of LA-2585 45.0 MG:  A new 6 Month, Subcutaneous Delivery System for Leuprolide Acetate for the treatment of Prostate Cancer Journal of Urology February 2006.
      24. Raymond C. Rosen, Robert Wood Johnson Medical School; William Fisher, University of Western Ontario; Gerald Brock, St. Joseph’s Medical Center; Gary Karlin, Lawrenceville Urology Practice; Peter Pommerville; Vardenafil Improves Erectile Function and Sexual Quality-of-Life in Men With ED and Their Partners, The Journal of Sex Research February 2006.
      25. Hellstrom WJ, Gittelman M, Karlin G et al.; Vardenafil for treatment of men with erectile dysfunction: Comparison of Phosphodiesterase Type 5 (PDE5) Inhibitors Controlled trial. Int J Clin Pract, August 2006.
      26. Hellstrom WJ, Gittelman M, Karlin G et al; Current Safety And Tolerability Issues In Men With Erectile Dysfunction Receiving PDE5 Inhibitors: Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial. J Sex Med 2005; 2: 415-25; Int J Clin Pract, September 2007.
      27. Irwin Goldstein, MD; LeRoy A. Jones, MD; Laurence H. Belkoff, DO; Gary S. Karlin, MD; Charles H. Bowden, MD; Craig A. Peterson, MS; Brenda A. Trask, BS; and Wesley W. Day, PhD: Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double-Blind Study in Men With Diabetes Mellitus. Mayo Clinic Proceedings; September 2012.
      28. GU ASCO 2013 MVA-BN-PRO poster: Phase 1 dose escalation trial of MVA-BN-PRO in men with non-metastatic castration resistant prostate cancer. Gary S. Karlin, AdvanceMed Research, Lawrenceville, NJ

      Presentations:

      • “Rapid Sequential Ureteral Dilator” Moldwin, R., Karlin, G., and Smith, A.D. 3rd World Congress on Endourology, New York, New York. 9/1985.
      • “Percutaneous Ureterostomy” Karlin, G., Moldwin, R., and Smith, A.D. 3rd World Congress on Endourology, New York, New York. 9/1985.
      • “The Greenberg Retractor for the Endourologist” Karlin, G. and Smith, A.D. 83rd Annual Meeting, American Urological Association, Anaheim, California. 5/1987.
      • “Endopyelotomy and Pyeloplasty: A Comparative Study” Karlin, G. 83rd Annual Meeting, American Urological Association, Anaheim, California. 5/1987.
      • “Endourologic Management of Upper Tract Candidiasis”, Karlin, G. New York Academy of Medicine, Valentine Essay Contest. New York, New York. 4/1987.
      • “Endopyelotomy: four-year Experience” Badlani, G., Karlin, G., and Smith, A.D. 5th World Congress on Endourology and ESWL Cairo, Egypt. 9/1987.
      • “Endourology Support System” Smith, A.D. and Karlin, G. 5th World Congress on Endourology and ESWL, Cairo, Egypt. 9/1987.
      • “Endopyelotomy: four-year Experience” Karlin, G. and Badlani, G. National Kidney Foundation. Washington, D.C. 12/1987.
      • “Papaverine Induced Fibrosis” Karlin, G. and Badlani, G. Nassau County Surgical Day. Nassau County Medical Center, East Meadow, New York. 12/1987.
      • “Corpus Cavernosum Fibrosis as a Result of Auto Injection of Papaverine For Treatment of Erectile Impotence: Ultrasound Study”, Karlin, G., New York Academy of Medicine. Valentine Essay Contest.  New York, New York. 3/1988.
      • “Accessory Phallic Urethra and Persistent Cloaca” Karlin, G., Brock, W., Pena, A. and Rich, M. 83rd Annual Meeting, American Urological Association. Boston, Massachusetts. 6/1988.
      • “Endopyelotomy for Primary UPJ Obstruction” Karlin, G., Smith, A.D. and Badlani, G. 83rd Annual Meeting, American Urological Association. Boston, Massachusetts. 1988.
      • ‘Percutaneous Nephrostomy in the Nondilated System”, Badlani, G., Karlin, G. and Smith, A.D. 6th World Congress on Endourology and ESWL, Paris, France. 9/1988.
      • “Endopyelotomy for Primary Versus Secondary UPJ Obstruction: Analysis of Results and Complications” Badlani,’G., Karlin, G. and Smith, A.D. 6th World Congress on Endourology and ESWL, Paris, France. 9/1988.
      • “Enzymuria Evaluation of Renal Tubular Injury Following ESWL with the Sonolith 2000” Karlin, G. and Smith, A.D. 5th Annual Symposium on Shock Wave Lithotripsy, Urinary and Biliary, Indianapolis, Indiana. 3/1989.
      • “Ultrasound Guided Extracorporeal Shock Wave Lithotripsy”, Karlin, G. and Smith, A.D. 5th Annual Symposium on Shock Wave Lithotripsy, Urinary and Biliary. Indianapolis, Indiana. 3/1989.
      • “Analysis of Calcium Oxalate Dihydrate and Monohydrate Agglomeration Using ESWL” Manne, J., Karlin, G., and Smith, A.D. 5th Annual Symposium on Shock Wave Lithotripsy, Urinary and Biliary. Indianapolis, Indiana. 3/1989.
      • “Ultrasound Localization of Renal Calculi” Karlin, G. and Smith, A.D. 5th Annual Symposium on Shock Wave Lithotripsy Urinary and Biliary. Indianapolis, Indiana. 3/1989.
      • ‘Percutaneous Access to the Superior Calyx; Renal Displacement Technique and Review of Options” Karlin, G. New York Academy of Medicine, Valentine Essay Contest. New York, New York. 4/1989.
      • “Percutaneous Access to the Superior Calyx: A New Technique” Karlin, G. and Smith, A.D. 83rd Annual Meeting, American Urological Association. Dallas, Texas. 5/1989.
      • “Morbid Obesity and the Disappearing Amplatz Sheath” Karlin, G. and Smith, A.D. 85th Annual Meeting of the American Urological Association. New Orleans, Louisiana. 5/1991.
      • “Impotence: What’s New in Diagnosis and Treatment” Karlin, G. Medical Grand Rounds, Mercer Medical Center, Trenton, New Jersey. 8/1991.
      • “Impotence – An Update” Annual Mercer County Medical Society Education Day Chauncey Conference Center Princeton, New Jersey. 10/1994.
      • “Diabetes and Sexual Dysfunction” Joslin Diabetes Center Princeton, New Jersey. 10/1995.
      • Vardenafil Improves Erection Quality Assessed by the Novel Erection Quality Scale in the Broad Population of Men with Erectile Dysfunction, European Society for Sexual Medicine, Copenhagen, Denmark. 12/2005.